People channel feed

Sen­ate con­firms Dr. Oz to lead Medicare agency amid HHS over­haul

Last month
Pharma
FDA+

Q&A: John Crow­ley warns biotech is 'dan­ger­ous­ly close' to break­ing, as tar­iff threat, mar­kets bat­ter in­dus­try

Last month
Pharma
FDA+

Ex­clu­sive: Mikael Dol­sten shares his post-Pfiz­er plans, in­clud­ing ad­vis­ing an AI uni­corn with phar­ma dreams

Last month
AI

Arie Bellde­grun nabs two lead­ers for Vi­da Ven­tures amid plans for fourth fund

Last month

‘It’ll be a chal­lenge’: BIO chief Crow­ley ad­dress­es seis­mic FDA over­haul

Last month
Pharma
FDA+

Q&A: Demis Has­s­abis talks 'tur­bocharg­ing' Iso­mor­phic with $600M, ex­pand­ing in­to an­ti­bod­ies and the US

Last month
AI

Fir­ings sweep across FDA as for­mer lead­ers lament the gut­ting of drug agency

Last month
FDA+

Sanofi con­tin­ues its bet on R&D by poach­ing GSK’s head of de­vel­op­ment

Last month
Pharma

What’s next af­ter Marks? At FDA, ques­tions over more top ex­its and fu­ture vi­sion for drug agency

Last month
FDA+

In­spir­na, which was prepar­ing for a Phase 3 can­cer tri­al, has fold­ed

Last month
Startups

El­e­vate­Bio trims work­force by 17%

Last month
Startups
Cell/Gene Tx

Covid con­trar­i­an Bhat­tacharya is con­firmed as NIH chief, tak­ing over at a fraught mo­ment for fed­er­al re­search

Last month
FDA+

Lyn­dra Ther­a­peu­tics to wind down amid fund­ing hur­dles for long-act­ing drug tech­nol­o­gy

Last month
Startups

Sen­ate com­mit­tee backs Dr. Oz's nom­i­na­tion to lead CMS

Last month
Pharma

Il­lu­mi­na adds ac­tivist in­vestor to board, taps for­mer FDA head as chair

Last month
Diagnostics

Trump taps act­ing CDC chief Su­san Monarez for per­ma­nent role

Last month
FDA+

Cal­ley Means joins White House as a spe­cial gov­ern­ment em­ploy­ee, will as­sist with MA­HA poli­cies

Last month

Car­go Ther­a­peu­tics scraps R&D pipeline, ax­es bulk of work­force as it looks for an ex­it

Last month
R&D

Stem cell com­pa­ny bit.bio cuts quar­ter of staff, drops ther­a­peu­tics fo­cus

Last month
Cell/Gene Tx

Stoke CEO Ed Kaye to de­part short­ly af­ter ink­ing Bio­gen pact and be­fore its first Phase 3 tri­al

Last month

Ex­clu­sive: Foods­mart names for­mer Amwell ex­ec­u­tive as its new CEO

Last month
Health Tech

Up­dat­ed: No­var­tis re­vamps car­dio­vas­cu­lar com­mer­cial strat­e­gy as En­tresto patent cliff looms 

Last month
Pharma

George Church spin­out de­vel­op­ing ge­nom­i­cal­ly re­cod­ed or­gan­isms cuts most em­ploy­ees

Last month
Startups
R&D

HC Bio­science, a tR­NA biotech backed by ARCH and Take­da, shuts down

Last month
Startups
First page Previous page 12345 Next page Last page
A service from the Financial Times